[Recent experiences in the treatment of sleep disorders by Flunitrazepam. Double-blind study].
D000328:Adult; D000368:Aged; D001008:Anxiety Disorders / Q000150:complications; D001570:Benzodiazepinones / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003863:Depression / Q000150:complications; D004155:Diphenhydramine / Q000627:therapeutic use; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D005464:Fluorobenzenes / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008702:Methaqualone / Q000627:therapeutic use; D008875:Middle Aged; D009574:Nitro Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D010300:Parkinson Disease / Q000150:complications; D011604:Psychoses, Alcoholic / Q000150:complications; D012893:Sleep Wake Disorders / Q000188:drug therapy* / Q000209:etiology; D019966:Substance-Related Disorders / Q000150:complications
D001570:Benzodiazepinones; D004338:Drug Combinations; D005464:Fluorobenzenes; D006993:Hypnotics and Sedatives; D009574:Nitro Compounds; D008702:Methaqualone; D004155:Diphenhydramine
Ulteriore esperienza nel trattamentao dei disturbi del sonno con Flunitrazepam. Studio doppio-cieco.